ciprofloxacin has been researched along with cilastatin, imipenem drug combination in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (58.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kletchko, S; Nagappan, R | 1 |
| Baetz, R; Borner, K; Lebahn, K; Lode, H; Olschewski, P; Reinke, M; Sievers, H; Wagner, J; Wiley, E; Wintermantel, M | 1 |
| Caldwell, JW; Fink, MP; Heard, SO; Johnson, RH; Leeper, KV; Niederman, MS; Schentag, JJ; Siami, GA; Snydman, DR; Wunderink, RG | 1 |
| Bolash, NK; Liu, HH; Lynch, RA; McAnany, ME | 1 |
| Fink, M; Niederman, M; Reinhart, H; Snydman, D | 1 |
| Bjornson, HS; Bohnen, JM; Coulter, HO; Dellinger, EP; Echols, RM; Haverstock, DC; Hill, CS; Reinhart, HH; Rotstein, OD; Simms, HH; Solomkin, JS; Vogel, SB | 1 |
| Desaty, TM; Griffin, TJ; Heifetz, CL; Sesnie, JC; Shapiro, MA | 1 |
| Fukuda, H; Kawamura, Y | 1 |
| Asaoka, N; Honda, Y; Kibayashi, T; Kishimoto, M; Kurihara, T; Nanba, F; Okimoto, N; Osaki, K; Yamato, K | 1 |
| Chen, CH; Lin, CH; Lin, JS | 1 |
| Courtois, R; Danneels, P; Dubée, V; Eveillard, M; Kempf, M; Mahieu, R; Quinqueneau, C; Rihet, C; Vannier, C | 1 |
| Bower, WA; Bulitta, JB; Chatham-Stephens, K; Cook, R; Hendricks, K; Kennedy, JL; Mongkolrattanothai, T; Negron, ME; Person, MK; Shin, E; Yu, P | 1 |
1 review(s) available for ciprofloxacin and cilastatin, imipenem drug combination
| Article | Year |
|---|---|
Postexposure Prophylaxis and Treatment of Bacillus anthracis Infections: A Systematic Review and Meta-analyses of Animal Models, 1947-2019.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Bacillus anthracis; beta-Lactams; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Doxycycline; Glycopeptides; Humans; Levofloxacin; Lipopeptides; Models, Animal; Tetracyclines; United States | 2022 |
5 trial(s) available for ciprofloxacin and cilastatin, imipenem drug combination
| Article | Year |
|---|---|
Prospective randomized clinical trials of new quinolones versus beta-lactam antibiotics in lower respiratory tract infections.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Clavulanic Acids; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Ofloxacin; Pneumonia; Prospective Studies; Remission Induction; Respiratory Tract Infections; Sepsis; Ticarcillin | 1990 |
Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.
Topics: Adult; Aged; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Double-Blind Method; Drug Combinations; Drug Resistance, Microbial; Female; Hospitalization; Humans; Imipenem; Injections, Intravenous; Male; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Regression Analysis; Seizures | 1994 |
Susceptibility of bacterial isolates from complicated skin and skin structure infections to cefazolin, imipenem-cilastatin, ciprofloxacin and ofloxacin.
Topics: Adolescent; Adult; Anti-Infective Agents; Bacteria; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Ofloxacin; Skin Diseases, Bacterial; Soft Tissue Infections | 1995 |
Treatment of severe pneumonia in hospitalised patients. Results of a multicentre trial comparing i.v. ciprofloxacin with imipenem/cilastatin.
Topics: Aged; Anti-Infective Agents; APACHE; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Imipenem; Male; Middle Aged; Pneumonia; Prospective Studies | 1995 |
Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group.
Topics: Abdomen; Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Infections; Infusions, Intravenous; Metronidazole; Middle Aged; Treatment Outcome | 1996 |
6 other study(ies) available for ciprofloxacin and cilastatin, imipenem drug combination
| Article | Year |
|---|---|
Bilateral emphysematous pyelonephritis resolving to medical therapy.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Emphysema; Escherichia coli Infections; Female; Humans; Imipenem; Middle Aged; Pyelonephritis; Tomography, X-Ray Computed | 1992 |
Comparative therapeutic efficacy of clinafloxacin in a Pseudomonas aeruginosa mouse renal abscess model.
Topics: Abscess; Animals; Anti-Infective Agents; Area Under Curve; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Fluoroquinolones; Half-Life; Imipenem; Kidney; Kidney Diseases; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Treatment Outcome | 1998 |
[Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; beta-Alanine; Biphenyl Compounds; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Convulsants; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Imipenem; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Norfloxacin; Oxazines; Penicillin G; Quinolones; Seizures; Thienamycins | 2002 |
[Study of the cases with multidrug-resistant Pseudomonas aeruginosa by sputum culture].
Topics: Adult; Aged; Amikacin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Imipenem; Japan; Klebsiella pneumoniae; Male; Methicillin Resistance; Middle Aged; Pneumonia, Bacterial; Prognosis; Pseudomonas aeruginosa; Retrospective Studies; Sputum; Staphylococcus aureus; Time Factors | 2007 |
Bacteremia caused by Elizabethkingia meningoseptica in a mechanically ventilated patient successfully treated with imipenem-cilastatin and ciprofloxacin.
Topics: Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Flavobacteriaceae Infections; Humans; Imipenem; Male; Middle Aged | 2017 |
Cefoxitin-based combination for ESBL-producing Enterobacteriaceae endocarditis.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoxitin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Endocarditis; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Urinary Tract Infections | 2022 |